The Roche Global Access Program has sustainable HIV diagnostic solutions to countries battling the HIV/AIDS epidemic.
Through partnerships with national governments, local healthcare facilities, communities and international agencies, the Roche Global Access Program launched in 2014 with the hopes to provide universal access to reliable HIV diagnostic tools in countries with the highest disease burden.
Case Study: Access to HIV screening in Nigeria
Two years ago, Roche embarked on a heroic effort to provide HIV viral load diagnostic tests to Nigeria, a country with the second largest HIV epidemic in the world.1
There were 1.9 million people in Nigeria living with HIV in 2018, with an adult HIV prevalence of 1.5%, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). Additionally, there were 130,000 newly diagnosed HIV infections and 53,000 AIDS-related deaths that year.2
In early January 2018, Roche received a request to provide Nigeria with 340,000 HIV viral load diagnostic tests and all the associated consumables. To fulfill an order of this magnitude, different international Roche groups including Roche’s Global Operations and Supply Chain, Roche Molecular Diagnostics business team and the South African affiliate collaborated to complete the task and ensure all goods were transported carefully.